Market Summary

Introduction

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Anatomic Pathology Market Overview 

    3.1    Global Anatomic Pathology Market Historical Value (2017-2023) 
    3.2    Global Anatomic Pathology Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global  Anatomic Pathology Market Landscape*
    5.1    Global Anatomic Pathology Market: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Anatomic Pathology Market: Product Landscape 
        5.2.1    Analysis by Product Type
        5.2.2    Analysis by Technology
        5.2.3    Analysis by Application
6    Global Anatomic Pathology Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis
        6.3.1    Political
        6.3.2    Economic
        6.3.3    Social
        6.3.4    Technological
        6.3.5    Legal
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Anatomic Pathology Market Segmentation (2017-2032)
    7.1    Global Anatomic Pathology Market (2017-2032) by Product Type
        7.1.1    Market Overview
        7.1.2    Instruments
        7.1.3    Consumables
        7.1.4    Reagents
        7.1.5    Software
    7.2    Global Anatomic Pathology Market (2017-2032) by Technology
        7.2.1    Market Overview
        7.2.2    Histology
        7.2.3    Cytology
        7.2.4    Molecular Pathology
        7.2.5    Others
    7.3    Global Anatomic Pathology Market (2017-2032) by Application
        7.3.1    Market Overview
        7.3.2    Disease Diagnosis
        7.3.3    Drug Development
        7.3.4    Research
        7.3.5    Others
    7.4    Global Anatomic Pathology Market (2017-2032) by End User
        7.4.1    Market Overview
        7.4.2    Hospitals
        7.4.3    Diagnostic Laboratories
        7.4.4    Academic and Research Institutions
        7.4.5    Pharmaceutical and Biotechnology Companies
        7.4.6    Others
    7.5    Global Anatomic Pathology Market (2017-2032) by Region
        7.5.1    Market Overview
        7.5.2    North America
        7.5.3    Europe 
        7.5.4    Asia Pacific
        7.5.5    Latin America
        7.5.6    Middle East and Africa
8    North America  Anatomic Pathology Market (2017-2032)
    8.1    North America Anatomic Pathology Market (2017-2032) by Product Type
        8.1.1    Market Overview
        8.1.2    Instruments
        8.1.3    Consumables
        8.1.4    Reagents
        8.1.5    Software
    8.2    North America Anatomic Pathology Market (2017-2032) by Technology
        8.2.1    Market Overview
        8.2.2    Histology
        8.2.3    Cytology
        8.2.4    Molecular Pathology
        8.2.5    Others
    8.3    North America Anatomic Pathology Market (2017-2032) by Application
        8.3.1    Market Overview
        8.3.2    Disease Diagnosis
        8.3.3    Drug Development
        8.3.4    Research
        8.3.5    Others
    8.4    North America Anatomic Pathology Market (2017-2032) by End User
        8.4.1    Market Overview
        8.4.2    Hospitals
        8.4.3    Diagnostic Laboratories
        8.4.4    Academic and Research Institutions
        8.4.5    Pharmaceutical and Biotechnology Companies
        8.4.6    Others
    8.5    North America Anatomic Pathology Market (2017-2032) by Country
        8.5.1    United States of America
        8.5.2    Canada
9    Europe Anatomic Pathology Market (2017-2032)
    9.1    Europe Anatomic Pathology Market (2017-2032) by Product Type
        9.1.1    Market Overview
        9.1.2    Instruments
        9.1.3    Consumables
        9.1.4    Reagents
        9.1.5    Software
    9.2    Europe Anatomic Pathology Market (2017-2032) by Technology
        9.2.1    Market Overview
        9.2.2    Histology
        9.2.3    Cytology
        9.2.4    Molecular Pathology
        9.2.5    Others
    9.3    Europe Anatomic Pathology Market (2017-2032) by Application
        9.3.1    Market Overview
        9.3.2    Disease Diagnosis
        9.3.3    Drug Development
        9.3.4    Research
        9.3.5    Others
    9.4    Europe Anatomic Pathology Market (2017-2032) by End User
        9.4.1    Market Overview
        9.4.2    Hospitals
        9.4.3    Diagnostic Laboratories
        9.4.4    Academic and Research Institutions
        9.4.5    Pharmaceutical and Biotechnology Companies
        9.4.6    Others
    9.5    Europe Anatomic Pathology Market (2017-2032) by Country
        9.5.1    United Kingdom
        9.5.2    Germany
        9.5.3    France
        9.5.4    Italy
        9.5.5    Others
10    Asia Pacific Anatomic Pathology Market (2017-2032)
    10.1    Asia Pacific Anatomic Pathology Market (2017-2032) by Product Type
        10.1.1    Market Overview
        10.1.2    Instruments
        10.1.3    Consumables
        10.1.4    Reagents
        10.1.5    Software
    10.2    Asia Pacific Anatomic Pathology Market (2017-2032) by Technology
        10.2.1    Market Overview
        10.2.2    Histology
        10.2.3    Cytology
        10.2.4    Molecular Pathology
        10.2.5    Others
    10.3    Asia Pacific Anatomic Pathology Market (2017-2032) by Application
        10.3.1    Market Overview
        10.3.2    Disease Diagnosis
        10.3.3    Drug Development
        10.3.4    Research
        10.3.5    Others
    10.4    Asia Pacific Anatomic Pathology Market (2017-2032) by End User
        10.4.1    Market Overview
        10.4.2    Hospitals
        10.4.3    Diagnostic Laboratories
        10.4.4    Academic and Research Institutions
        10.4.5    Pharmaceutical and Biotechnology Companies
        10.4.6    Others
    10.5    Asia Pacific Anatomic Pathology Market (2017-2032) by Country
        10.5.1    China
        10.5.2    Japan
        10.5.3    India
        10.5.4    ASEAN
        10.5.5    Australia
        10.5.6    Others
11    Latin  America Anatomic Pathology Market (2017-2032)
    11.1    Latin America Anatomic Pathology Market (2017-2032) by Product Type
        11.1.1    Market Overview
        11.1.2    Instruments
        11.1.3    Consumables
        11.1.4    Reagents
        11.1.5    Software
    11.2    Latin America Anatomic Pathology Market (2017-2032) by Technology
        11.2.1    Market Overview
        11.2.2    Histology
        11.2.3    Cytology
        11.2.4    Molecular Pathology
        11.2.5    Others
    11.3    Latin America Anatomic Pathology Market (2017-2032) by Application
        11.3.1    Market Overview
        11.3.2    Disease Diagnosis
        11.3.3    Drug Development
        11.3.4    Research
        11.3.5    Others
    11.4    Latin America Anatomic Pathology Market (2017-2032) by End User
        11.4.1    Market Overview
        11.4.2    Hospitals
        11.4.3    Diagnostic Laboratories
        11.4.4    Academic and Research Institutions
        11.4.5    Pharmaceutical and Biotechnology Companies
        11.4.6    Others
    11.5    Latin America Anatomic Pathology Market (2017-2032) by Country
        11.5.1    Brazil
        11.5.2    Argentina
        11.5.3    Mexico
        11.5.4    Others
12    Middle East  and Africa Anatomic Pathology Market (2017-2032)
    12.1    Middle East and Africa Anatomic Pathology Market (2017-2032) by Product Type
        12.1.1    Market Overview
        12.1.2    Instruments
        12.1.3    Consumables
        12.1.4    Reagents
        12.1.5    Software
    12.2    Middle East and Africa Anatomic Pathology Market (2017-2032) by Technology
        12.2.1    Market Overview
        12.2.2    Histology
        12.2.3    Cytology
        12.2.4    Molecular Pathology
        12.2.5    Others
    12.3    Middle East and Africa Anatomic Pathology Market (2017-2032) by Application
        12.3.1    Market Overview
        12.3.2    Disease Diagnosis
        12.3.3    Drug Development
        12.3.4    Research
        12.3.5    Others
    12.4    Middle East and Africa Anatomic Pathology Market (2017-2032) by End User
        12.4.1    Market Overview
        12.4.2    Hospitals
        12.4.3    Diagnostic Laboratories
        12.4.4    Academic and Research Institutions
        12.4.5    Pharmaceutical and Biotechnology Companies
        12.4.6    Others
    12.5    Middle East and Africa Anatomic Pathology Market (2017-2032) by Country
        12.5.1    Saudi Arabia
        12.5.2    United Arab Emirates
        12.5.3    Nigeria
        12.5.4    South Africa
        12.5.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Patent Analysis
    14.1     Analysis by Type of Patent
    14.2     Analysis by Publication Year
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Patent Age
    14.5     Analysis by CPC Analysis
    14.6     Analysis by Patent Valuation 
    14.7     Analysis by Key Players
15    Grants Analysis
    15.1    Analysis by Year
    15.2    Analysis by Amount Awarded
    15.3    Analysis by Issuing Authority
    15.4    Analysis by Grant Application
    15.5    Analysis by Funding Institute
    15.6    Analysis by NIH Departments
    15.7    Analysis by Recipient Organization 
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Strategic Initiatives
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership and Collaborations
    17.3    Analysis by Joint Ventures
    17.4    Analysis by Leading Players
    17.5    Analysis by Geography 
18    Supplier Landscape
    18.1    Market Share Analysis, By Region (Top 5 Companies)
        18.1.1    Market Share Analysis: Global
        18.1.2    Market Share Analysis: North America
        18.1.3    Market Share Analysis: Europe
        18.1.4    Market Share Analysis: Asia Pacific
        18.1.5    Market Share Analysis: Others
    18.2    F. Hoffmann-La Roche Ltd 
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Company News and Development
        18.2.5    Certifications 
    18.3    Thermo Fisher Scientific Inc.
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Company News and Development
        18.3.5    Certifications
    18.4     Agilent Technologies, Inc.
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Company News and Development
        18.4.5    Certifications
    18.5    Leica Biosystems Nussloch Gmb H (a Danaher Company)
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Company News and Development
        18.5.5    Certifications
    18.6    VWR International, LLC.
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Company News and Development
        18.6.5    Certifications
    18.7    Fujifilm Holdings Corporation
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Company News and Development
        18.7.5    Certifications
    18.8    Koninklijke Philips N .V.
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Company News and Development
        18.8.5    Certifications
    18.9    Abbott Laboratories
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Company News and Development
        18.9.5    Certifications
    18.10    Becton, Dickinson and Company (BD)
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Company News and Development
        18.10.5    Certifications
    18.11    Sysmex Corporation
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Company News and Development
        18.11.5    Certifications
19    Global Anatomic Pathology Market – Distribution Model (Additional Insight)
    19.1     Overview 
    19.2     Potential Distributors 
    19.3     Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

 

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

*Additional insights provided are customizable as per client requirements.

*The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

*The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124